Editorial

Precision treatment in endocrine tumors

Expand

Received date: 2023-08-21

  Online published: 2024-01-09

Cite this article

NING Guang . Precision treatment in endocrine tumors[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(04) : 225 -226 . DOI: 10.16138/j.1673-6087.2023.04.001

References

[1] 陈家伦, 宁光. 临床内分泌学(第二版)[M]. 2022: 1691-1694.
[2] 周薇薇, 苏颋为, 姜蕾, 等. 改良岩下窦静脉采血在库欣病诊断中的应用[J]. 中华内分泌代谢杂志, 2016, 32(3): 196-200.
[3] Ye L, Zhao Z, Ren H, et al. A multiclassifier system to identify and subtype congenital adrenal hyperplasia based on circulating steroid hormones[J]. J Clin Endocrinol Metab, 2022, 107(8): e3304-e3312.
[4] Cao Y, He M, Gao Z, et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome[J]. Science, 2014, 344(6186): 913-917.
[5] Ye L, Zhou X, Huang F, et al. The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing[J]. Nat Commun, 2017, 8: 15533.
[6] Zhong X, Ye L, Su T, et al. Establishment and evaluation of a novel biomarker-based nomogram for malignant phaeochromocytomas and paragangliomas[J]. Clin Endocrinol (Oxf), 2017, 87(2): 127-135.
[7] Zhang C, Wu L, Jiang L, et al. KCNJ5 mutation contributes to complete clinical success in aldosterone-producing adenoma[J]. Endocr Pract, 2021, 27(7): 736-742.
[8] 宁光, 刘茂河, 王卫庆, 等. 输液泵: ZL201010615266.9[P]. 2014-01-01.
Outlines

/